Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
Immune cell engagers (ICEs) are an emerging class of immunotherapies designed to harness the immune system’s anti-tumor potential through precise targeting and activation of immune effector cells. By engaging T cells, natural killer (NK) cells, and phagocytes, ICEs overcome challenges such as immune...
Saved in:
| Main Authors: | Hyukmin In, Minkyoung Park, Hyeonsik Lee, Kyung Ho Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Antibodies |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4468/14/1/16 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Advancements in drug development: exploring bi-specific antibodies as promising therapeutic strategies in oncology
by: Urs M. Weber, et al.
Published: (2025-07-01) -
Innovative strategies for T cell engagers for cancer immunotherapy
by: Cristina Bergamaschi, et al.
Published: (2025-12-01) -
Measuring enablers and indicators of employee engagement: Internal validity of the Flow@Work engagement survey
by: Melinde Coetzee, et al.
Published: (2025-02-01) -
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01) -
Development and Validation of the Interpreting Learning Engagement Scale (ILES)
by: Wenting Yu, et al.
Published: (2024-12-01)